Patent · US Expired

Piperazine and homopiperazine compounds

US4529729A · kind A · utility

2Cited by
0References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 20, 1984
Grant dateJul 16, 1985
Priority date
Expiry dateJun 20, 2004

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D409/12
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Piperazine and homopiperazine compounds of the formula: ##STR1## in which: A is a hydrocarbon radical from C.sub.3 to C.sub.5, in a straight or branched chain, which may contain one or two double bonds, and optionally substituted by one or more OH; PA0 B is CH or a nitrogen atom; PA0 m is 2 or 3; PA0 X--Y-- represents --CH.dbd.CH--(CR'R").sub.n - in which n is zero or 1, and R' and R" are hydrogen or methyl; PA0 Z is oxygen or sulfur, PA0 R is hydrogen, alkyl from C.sub.1 to C.sub.5, cycloalkyl from C.sub.3 to C.sub.7, or phenyl optionally substituted by fluorine, chlorine or alkyl from C.sub.1 to C.sub.5, and PA0 T is hydrogen, fluorine, chlorine or alkyl from C.sub.1 to C.sub.5. These compounds and physiologically tolerable acid addition salts thereof may be used as medicines especially in the treatment of all kinds of tissular hypoxia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.